Pardi N - Search Results

1

Development of an mRNA-lipid nanoparticle vaccine against Lyme disease.

Pine M, Arora G, Hart TM, Bettini E, Gaudette BT, Muramatsu H, Tombácz I, Kambayashi T, Tam YK, Brisson D, Allman D, Locci M, Weissman D, Fikrig E, Pardi N. Pine M, et al. Among authors: pardi n. Mol Ther. 2023 Sep 6;31(9):2702-2714. doi: 10.1016/j.ymthe.2023.07.022. Epub 2023 Aug 2. Mol Ther. 2023. PMID: 37533256 Free article.

2

Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and Ark mRNA level.

Bodai L, Pardi N, Ujfaludi Z, Bereczki O, Komonyi O, Balint E, Boros IM. Bodai L, et al. Among authors: pardi n. J Biol Chem. 2007 Dec 14;282(50):36386-93. doi: 10.1074/jbc.M705547200. Epub 2007 Oct 12. J Biol Chem. 2007. PMID: 17933869 Free article.

3

In vivo effects of abolishing the single canonical sumoylation site in the C-terminal region of Drosophila p53.

Pardi N, Vámos E, Ujfaludi Z, Komonyi O, Bodai L, Boros IM. Pardi N, et al. Acta Biol Hung. 2011 Dec;62(4):397-412. doi: 10.1556/ABiol.62.2011.4.6. Acta Biol Hung. 2011. PMID: 22119869

4

TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its function.

Bereczki O, Ujfaludi Z, Pardi N, Nagy Z, Tora L, Boros IM, Balint E. Bereczki O, et al. Among authors: pardi n. BMC Mol Biol. 2008 Jun 12;9:57. doi: 10.1186/1471-2199-9-57. BMC Mol Biol. 2008. PMID: 18549481 Free PMC article.

5

In vitro transcription of long RNA containing modified nucleosides.

Pardi N, Muramatsu H, Weissman D, Karikó K. Pardi N, et al. Methods Mol Biol. 2013;969:29-42. doi: 10.1007/978-1-62703-260-5_2. Methods Mol Biol. 2013. PMID: 23296925 Review.

6

HPLC purification of in vitro transcribed long RNA.

Weissman D, Pardi N, Muramatsu H, Karikó K. Weissman D, et al. Among authors: pardi n. Methods Mol Biol. 2013;969:43-54. doi: 10.1007/978-1-62703-260-5_3. Methods Mol Biol. 2013. PMID: 23296926

7

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.

Pardi N, Tuyishime S, Muramatsu H, Kariko K, Mui BL, Tam YK, Madden TD, Hope MJ, Weissman D. Pardi N, et al. J Control Release. 2015 Nov 10;217:345-51. doi: 10.1016/j.jconrel.2015.08.007. Epub 2015 Aug 8. J Control Release. 2015. PMID: 26264835 Free PMC article.

8

Nucleoside Modified mRNA Vaccines for Infectious Diseases.

Pardi N, Weissman D. Pardi N, et al. Methods Mol Biol. 2017;1499:109-121. doi: 10.1007/978-1-4939-6481-9_6. Methods Mol Biol. 2017. PMID: 27987145

9

Measuring the Adjuvant Activity of RNA Vaccines.

Pardi N, Weissman D. Pardi N, et al. Methods Mol Biol. 2017;1499:143-153. doi: 10.1007/978-1-4939-6481-9_8. Methods Mol Biol. 2017. PMID: 27987147

10

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.

Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, Yu JS, McGee CE, Sempowski GD, Mui BL, Tam YK, Huang YJ, Vanlandingham D, Holmes VM, Balachandran H, Sahu S, Lifton M, Higgs S, Hensley SE, Madden TD, Hope MJ, Karikó K, Santra S, Graham BS, Lewis MG, Pierson TC, Haynes BF, Weissman D. Pardi N, et al. Nature. 2017 Mar 9;543(7644):248-251. doi: 10.1038/nature21428. Epub 2017 Feb 2. Nature. 2017. PMID: 28151488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page